Goldline Pharmaceutical IPO Subscription
The Goldline Pharmaceutical IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
As per the latest subscription update, the Goldline Pharmaceutical IPO has received bids for 1,53,86,88,000 shares against 18,30,000 shares offered, resulting in an overall subscription of 840.81x. the NII category is subscribed 1,662.39x, Retail Investors 881.15x, and QIBs 180.22x. Within the NII category, BNII is subscribed 2,011.14x, while SNII is subscribed 980.75x.
- Retail
- 881.15x
- NII
- 1662.39x
- QIB
- 180.22x
- Total
- 840.81x
Current GMP
₹15 (+34.88%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Goldline Pharmaceutical IPO Subscription Details ( Thu, 14 May 26 01:45 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 540,000 | 97,317,000 | 180.22x |
| Non-Institutional | 390,000 | 648,333,000 | 1662.39x |
| BNII (>₹10L) | 258,000 | 518,874,000 | 2011.14x |
| SNII (₹2L–₹10L) | 132,000 | 129,459,000 | 980.75x |
| Retail Investors | 900,000 | 793,038,000 | 881.15x |
| Total | 1,830,000 | 1,538,688,000 | 840.81x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved Apps | Applied Apps | Times (x) |
|---|---|---|---|
| Non-Institutional | 43 | 33,760 | 779.08x |
| BNII (>₹10L) | 29 | 20,429 | 712.64x |
| SNII (₹2L–₹10L) | 15 | 13,331 | 908.93x |
| Retail Investors | 150 | 132,173 | 881.15x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Goldline Pharmaceutical IPO Live Subscription Status?
You can check the Goldline Pharmaceutical IPO live subscription status on the IPO Master App or the official websites of the BSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Goldline Pharmaceutical IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Goldline Pharmaceutical IPO was subscribed 881.15 times as of Thu, May 14, 2026 07:15 PM. The public issue closed on Thu, May 14, 2026 for bidding.
How to subscribe Goldline Pharmaceutical IPO?
Investors can apply for the Goldline Pharmaceutical IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Goldline Pharmaceutical IPO subscribed?
The Goldline Pharmaceutical IPO was subscribed 840.81x times at the close of bidding period on Thu, May 14, 2026.
How to check Goldline Pharmaceutical IPO allotment?
The Goldline Pharmaceutical IPO allotment was finalized on Fri, May 15, 2026. You can check the Goldline Pharmaceutical IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Goldline Pharmaceutical IPO Be Listed?
The Goldline Pharmaceutical IPO was listed on Tue, May 19, 2026, on the BSE.
What is the Goldline Pharmaceutical IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Goldline Pharmaceutical IPO was subscribed 180.22 times as of Thu, May 14, 2026 07:15 PM.